Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Residual Inflammatory Risk In Contemporary Statin Treated Patients: A Collaborative Analyses Of 31,197 Participants In The Prominent, Reduce-it, And Strength Trials